Cambridge Cognition Holdings (COG)

Sector:

Health Care

Index:

FTSE AIM All-Share

38.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 66.00
  • 52 Week Low: 19.00
  • Currency: UK Pounds
  • Shares Issued: 31.17m
  • Volume: 31,502
  • Market Cap: £11.84m
  • RiskGrade: 398

Cambridge Cognition inks multiple new contracts for virtual trials

By Iain Gilbert

Date: Wednesday 27 May 2020

LONDON (ShareCast) - (Sharecast News) - Digital brain health products developer Cambridge Cognition has secured several new contracts to support pharmaceutical clients in delivering virtual clinical trials, including two contracts collectively worth over £1m.
Cambridge Cognition said on Wednesday that as efforts to curb Covid-19 transmission rates increase, the pharmaceutical industry has turned to delivering virtual clinical trials and expects that most of the cash from these new deals will be recognised the 2020 financial year.

"With pharmaceutical companies searching for options to continue trials outside of the clinic, the company has seen increased interest in virtual or part-virtual assessments since Covid-19 driven lockdowns began," said the firm.

The AIM-listed group noted that the first of the larger trials leveraged its digital health capabilities in a new clinical field, while the second was a Phase II study investigating the cognitive impact of a new drug for a neurodegenerative disorder.

Chief executive Matthew Stork said: "There is a great interest being shown in moving to virtual trials and we expect this to be a fast growth segment of the market for years to come, even once the Covid-19 crisis has eased.

"The combination of our technological solutions for virtual trials, our regulatory compliant platforms and experienced study management team have made us ideally placed to meet the evolving demands of the industry."

As of 1000 BST, Cambridge shares were up 6.12% at 26p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

COG Market Data

Currency UK Pounds
Share Price 38.00p
Change Today -1.00p
% Change -2.56 %
52 Week High 66.00
52 Week Low 19.00
Volume 31,502
Shares Issued 31.17m
Market Cap £11.84m
RiskGrade 398

COG Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
13.82% below the market average13.82% below the market average13.82% below the market average13.82% below the market average13.82% below the market average
56.76% above the sector average56.76% above the sector average56.76% above the sector average56.76% above the sector average56.76% above the sector average
Price Trend
22.99% below the market average22.99% below the market average22.99% below the market average22.99% below the market average22.99% below the market average
45% below the sector average45% below the sector average45% below the sector average45% below the sector average45% below the sector average
Income Not Available
Growth
55.99% below the market average55.99% below the market average55.99% below the market average55.99% below the market average55.99% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

COG Dividends

No dividends found

Trades for 03-Jul-2020

Time Volume / Share Price
16:35 95 @ 38.00p
15:51 10,000 @ 39.50p
14:39 12,800 @ 39.50p
11:00 25,640 @ 38.50p
11:32 5,107 @ 39.00p

COG Key Personnel

Chair Michael Geoffrey Lewis
CFO Nick Walters
CEO Matthew Stork

Top of Page